American Portfolios Advisors Night Hawk Biosciences, Inc. Transaction History

American Portfolios Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Mar 21, 2023	BUY	$2.1 - $3.54 $598 - $1,008	285 New	285 $872,000
Q4 2021 Mar 21, 2023	BUY	$3.04 - $6.01 $866 - $1,712	285 New	285 $866,000
Q3 2021 Mar 22, 2023	BUY	$5.9 - $7.44 $1,681 - $2,120	285 New	285 $1.7 Million
Q2 2021 Mar 22, 2023	BUY	$5.78 - $9.6 $1,647 - $2,736	285 New	285 $1.92 Million
Q1 2021 Mar 22, 2023	BUY	$5.67 - $12.54 $1,615 - $3,573	285 New	285 $2.08 Million
Q4 2020 Mar 22, 2023	BUY	$5.28 - $9.59 $1,504 - $2,733	285 New	285 $1.53 Million

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.